{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T03:32:35Z","timestamp":1763436755613,"version":"3.37.3"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10147-022-02251-4","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:03:02Z","timestamp":1671267782000},"page":"28-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Current clinical perspective of urological oncology in the adolescent and young adult generation"],"prefix":"10.1007","volume":"28","author":[{"given":"Ryohei","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6699-4616","authenticated-orcid":false,"given":"Hiroshi","family":"Asanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mototsugu","family":"Oya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,17]]},"reference":[{"key":"2251_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10147-021-02064-x","volume":"27","author":"K Nakata","year":"2022","unstructured":"Nakata K, Hiyama E, Katanoda K et al (2022) Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy. Int J Clin Oncol 27:7\u201315","journal-title":"Int J Clin Oncol"},{"key":"2251_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/jjco\/hyx070","volume":"47","author":"K Katanoda","year":"2017","unstructured":"Katanoda K, Shibata A, Matsuda T et al (2017) Childhood, adolescent and young adult cancer incidence in Japan in 2009\u20132011. Jpn J Clin Oncol 47:762\u2013771","journal-title":"Jpn J Clin Oncol"},{"key":"2251_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ucl.2015.04.001","volume":"42","author":"SM Stevenson","year":"2015","unstructured":"Stevenson SM, Lowrance WT (2015) Epidemiology and diagnosis of testis cancer. Urol Clin North Am 42:269\u2013275","journal-title":"Urol Clin North Am"},{"key":"2251_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/978-3-319-33679-4_12","volume-title":"Cancer in adolescents and young adults","author":"B Hayes-Lattin","year":"2017","unstructured":"Hayes-Lattin B, Bleyer A (2017) Testicular cancer. In: Bleyer A, Barr R, Ries L et al (eds) Cancer in adolescents and young adults, 2nd edn. Springer, Switzerland, pp 307\u2013318"},{"key":"2251_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1034\/j.1600-0463.2003.11101031.x","volume":"111","author":"NE Skakkeb\u00e6k","year":"2003","unstructured":"Skakkeb\u00e6k NE, Holm M, Hoei-Hansen C et al (2003) Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis. APMIS 111:1\u201311","journal-title":"APMIS"},{"key":"2251_CR6","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0140-6736(81)91165-X","volume":"2","author":"GJ Bosl","year":"1981","unstructured":"Bosl GJ, Vogelzang NJ, Goldman A et al (1981) Impact of delay in diagnosis on clinical stage of testicular cancer. Lancet 2:970\u2013973","journal-title":"Lancet"},{"key":"2251_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/jayao.2021.0020","volume":"11","author":"MJ Rovito","year":"2022","unstructured":"Rovito MJ, Adams WB, Craycraft M et al (2022) The association between testicular self-examination and stages of testicular cancer diagnosis: a cross-sectional analysis. J Adolesc Young Adult Oncol 11:41\u201347","journal-title":"J Adolesc Young Adult Oncol"},{"key":"2251_CR8","volume-title":"The TNM classification of malignant tumours","author":"JD Brierley","year":"2016","unstructured":"Gospodarowicz MK, Mason M (2017) Urological tumours. In: Brierley JD, Gospodarowicz MK, Wittekind C (eds) TNM classification of malignant tumours, 8th edn. John Wiley and Sons, Oxford, UK; Hoboken, NJ, pp 187\u2013209","edition":"8"},{"key":"2251_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Brimo F, Srigley JR, Ryan CJ et al (2017) Testis. In: Amin MB, Edge SB, Greene FL et al (eds) AJCC cancer staging manual, 8th edn. Springer, New York, pp 735\u2013743","edition":"8"},{"key":"2251_CR10","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1200\/JCO.20.03292","volume":"39","author":"J Beyer","year":"2021","unstructured":"International Germ Cell Cancer Classification Update Consortium, Beyer J, Collette L, Sauv\u00e9 N et al (2021) Survival and new prognosticators in metastatic seminoma: results from the IGCCCG-update consortium. J Clin Oncol 39:1553\u20131562","journal-title":"J Clin Oncol"},{"key":"2251_CR11","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1200\/JCO.20.03296","volume":"39","author":"S Gillessen","year":"2021","unstructured":"International Germ Cell Cancer Classification Update Consortium, Gillessen S, Sauv\u00e9 N, Collette L et al (2021) Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG update consortium. J Clin Oncol 39:1563\u20131574","journal-title":"J Clin Oncol"},{"key":"2251_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/cncr.33273","volume":"127","author":"F Shaikh","year":"2021","unstructured":"Shaikh F, Stark D, Fonseca A et al (2021) Outcomes of adolescent males with extracranial metastatic germ cell tumors: a report from the Malignant Germ Cell Tumor International Consortium. Cancer 127:193\u2013202","journal-title":"Cancer"},{"key":"2251_CR13","unstructured":"EAU guidelines on testicular cancer. https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Testicular-Cancer-2022.pdf. April 2022"},{"key":"2251_CR14","unstructured":"Clinical practice guidelines for testicular tumor 2015 edition by the Japanese Urological Association (in Japanese)"},{"key":"2251_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0015-0282(97)81465-3","volume":"68","author":"J Pont","year":"1997","unstructured":"Pont J, Albrecht W (1997) Fertility after chemotherapy for testicular germ cell cancer. Fertil Steril 68:1\u20135","journal-title":"Fertil Steril"},{"key":"2251_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.urolonc.2019.02.009","volume":"38","author":"JA Halpern","year":"2020","unstructured":"Halpern JA, Hill R, Brannigan RE (2020) Guideline based approach to male fertility preservation. Urol Oncol 38:31\u201335","journal-title":"Urol Oncol"},{"key":"2251_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jpedsurg.2015.10.039","volume":"51","author":"BC Gulack","year":"2016","unstructured":"Gulack BC, Rialon KL, Englum BR et al (2016) Factors associated with survival in pediatric adrenocortical carcinoma: an analysis of the National Cancer Data Base (NCDB). J Pediatr Surg 51:172\u2013177","journal-title":"J Pediatr Surg"},{"key":"2251_CR18","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-18-0608","volume":"179","author":"M Fassnacht","year":"2018","unstructured":"Fassnacht M, Dekkers OM, Else T et al (2018) European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 179:G1\u2013G46","journal-title":"Eur J Endocrinol"},{"key":"2251_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/cncr.24030","volume":"115","author":"M Fassnacht","year":"2009","unstructured":"German Adrenocortical Carcinoma Registry Group, European Network for the Study of Adrenal Tumors, Fassnacht M, Johanssen S, Quinkler M et al (2009) Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification. Cancer 115:243\u2013250","journal-title":"Cancer"},{"key":"2251_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","volume":"13","author":"LM Weiss","year":"1989","unstructured":"Weiss LM, Medeiros LJ, Vickery AL Jr (1989) Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13:202\u2013206","journal-title":"Am J Surg Pathol"},{"key":"2251_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/bjs.10414","volume":"104","author":"S Gaujoux","year":"2017","unstructured":"Gaujoux S, Mihai R (2017) European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma. Br J Surg 104:358\u2013376","journal-title":"Br J Surg"},{"key":"2251_CR22","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1210\/jc.2010-0803","volume":"95","author":"M Fassnacht","year":"2010","unstructured":"German ACC Registry Group, Fassnacht M, Johanssen S, Fenske W et al (2010) Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers. J Clin Endocrinol Metab 95:4925\u20134932","journal-title":"J Clin Endocrinol Metab"},{"key":"2251_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4103\/0971-9261.214454","volume":"22","author":"J Mittal","year":"2017","unstructured":"Mittal J, Manikandan R, Dorairajan LN et al (2017) Recurrent malignant pheochromocytoma with lymph nodal metastasis in a child: a rare case. J Indian Assoc Pediatr Surg 22:242\u2013244","journal-title":"J Indian Assoc Pediatr Surg"},{"key":"2251_CR24","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","volume":"31","author":"M Fassnacht","year":"2020","unstructured":"ESMO Guidelines Committee, Fassnacht M, Assie G, Baudin E et al (2020) Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 31:1476\u20131490","journal-title":"Ann Oncol"},{"key":"2251_CR25","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1056\/NEJMoa020152","volume":"346","author":"HP Neumann","year":"2002","unstructured":"Freiburg-Warsaw-Columbus Pheochromocytoma Study Group, Neumann HP, Bausch B, McWhinney SR et al (2002) Germline mutations in nonsyndromic pheochromocytoma. N Engl J Med 346:1459\u20131466","journal-title":"N Engl J Med"},{"key":"2251_CR26","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.jpedsurg.2017.11.055","volume":"53","author":"Z Dokumcu","year":"2018","unstructured":"Dokumcu Z, Divarci E, Ertan Y et al (2018) Laparoscopic adrenalectomy in children: a 25-case series and review of the literature. J Pediatr Surg 53:1800\u20131805","journal-title":"J Pediatr Surg"},{"key":"2251_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/cen.12341","volume":"80","author":"LT van Hulsteijn","year":"2014","unstructured":"van Hulsteijn LT, Niemeijer ND, Dekkers OM et al (2014) (131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis. Clin Endocrinol 80:487\u2013501","journal-title":"Clin Endocrinol"},{"key":"2251_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12672-017-0284-7","volume":"8","author":"S Asai","year":"2017","unstructured":"Asai S, Katabami T, Tsuiki M et al (2017) Controlling tumor progression with cyclophosphamide, vincristine, and dacarbazine treatment improves survival in patients with metastatic and unresectable malignant pheochromocytomas\/paragangliomas. Horm Cancer 8:108\u2013118","journal-title":"Horm Cancer"},{"key":"2251_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fonc.2014.00166","volume":"4","author":"J Vogel","year":"2014","unstructured":"Vogel J, Atanacio AS, Prodanov T et al (2014) External beam radiation therapy in treatment of malignant pheochromocytoma and paraganglioma. Front Oncol 4:166","journal-title":"Front Oncol"},{"key":"2251_CR30","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1002\/ijc.28913","volume":"135","author":"J Hadoux","year":"2014","unstructured":"Hadoux J, Favier J, Scoazec JY et al (2014) SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma. Int J Cancer 135:2711\u20132720","journal-title":"Int J Cancer"},{"key":"2251_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12022-011-9189-0","volume":"23","author":"J Favier","year":"2012","unstructured":"Favier J, Igaz P, Burnichon N et al (2012) Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma. Endocr Pathol 23:34\u201342","journal-title":"Endocr Pathol"},{"key":"2251_CR32","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1542\/peds.2005-2299","volume":"118","author":"TH Pham","year":"2006","unstructured":"Pham TH, Moir C, Thompson GB et al (2006) Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center. Pediatrics 118:1109\u20131117","journal-title":"Pediatrics"},{"key":"2251_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/978-3-319-33679-4_17","volume-title":"Cancer in adolescents and young adults","author":"M Leahy","year":"2017","unstructured":"Leahy M, Spreafico F, Bleyer A (2017) Cancer of the kidney, bladder, and prostate. In: Bleyer A, Barr R, Ries L et al (eds) Cancer in adolescents and young adults, 2nd edn. Springer, Switzerland, pp 429\u2013451"},{"key":"2251_CR34","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1053\/j.seminoncol.2016.09.001","volume":"43","author":"LS Schmidt","year":"2016","unstructured":"Schmidt LS, Linehan WM (2016) Genetic predisposition to kidney cancer. Semin Oncol 43:566\u2013574","journal-title":"Semin Oncol"},{"key":"2251_CR35","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","volume":"34","author":"P Argani","year":"2010","unstructured":"Argani P, Aulmann S, Illei PB et al (2010) A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol 34:1395\u20131406","journal-title":"Am J Surg Pathol"},{"key":"2251_CR36","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/his.14634","volume":"80","author":"T Denize","year":"2022","unstructured":"Denize T, Massa S, Valent A et al (2022) Renal cell carcinoma in children and adolescents: a retrospective study of a French- Italian series of 93 cases. Histopathology 80:928\u2013945","journal-title":"Histopathology"},{"key":"2251_CR37","first-page":"308","volume":"5","author":"JE Sausville","year":"2009","unstructured":"Sausville JE, Hernandez DJ, Argani P et al (2009) Pediatric renal cell carcinoma. J Pediatr Urol 5:308\u2013314","journal-title":"J PediatrUrol"},{"key":"2251_CR38","first-page":"472","volume":"18","author":"N Liu","year":"2019","unstructured":"Liu N, Qu F, Wei K et al (2019) Incidence and significance of psammoma bodies in Xp11.2 translocation renal cell carcinoma and papillary renal cell carcinoma. Oncol Lett 18:472\u2013478","journal-title":"Oncol Lett"},{"key":"2251_CR39","unstructured":"EAU guidelines on renal cell carcinoma. https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Renal-Cell-Carinoma-2022.pdf. April 2022"},{"key":"2251_CR40","unstructured":"Clinical practice guidelines for renal cancer 2017 edition by the Japanese Urological Association (in Japanese)"},{"key":"2251_CR41","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/cncr.20548","volume":"101","author":"JI Geller","year":"2004","unstructured":"Geller JI, Dome JS (2004) Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma.\nCancer 101:1575\u20131583","journal-title":"Cancer"},{"key":"2251_CR42","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.2147\/DDDT.S109640","volume":"11","author":"A Bellesoeur","year":"2017","unstructured":"Bellesoeur A, Carton E, Alexandre J et al (2017) Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy. Drug Des Devel Ther 11:2801\u20132811","journal-title":"Drug Des Devel Ther"},{"key":"2251_CR43","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","volume":"373","author":"RJ Motzer","year":"2015","unstructured":"Motzer RJ, Escudier B, McDermott DF et al (2015) Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl J Med 373:1803\u20131813","journal-title":"N Engl J Med"},{"key":"2251_CR44","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/annonc\/mdq029","volume":"21","author":"GG Malouf","year":"2010","unstructured":"Malouf GG, Camparo P, Oudard S et al (2010) Targeted agents in metastatic Xp11 translocation\/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network. Ann Oncol 21:1834\u20131838","journal-title":"Ann Oncol"},{"key":"2251_CR45","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1097\/MPH.0b013e318267fb12","volume":"34","author":"P Indolfi","year":"2012","unstructured":"Indolfi P, Spreafico F, Collini P et al (2012) Metastatic renal cell carcinoma in children and adolescents: a 30-year unsuccessful story. J Pediatr Hematol Oncol 34:e277\u2013e281","journal-title":"J Pediatr Hematol Oncol"},{"key":"2251_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41572-021-00308-8","volume":"7","author":"F Spreafico","year":"2021","unstructured":"Spreafico F, Fernandez CV, Brok J et al (2021) Wilms tumour. Nat Rev Dis Primers 7:75","journal-title":"Nat Rev Dis Primers"},{"key":"2251_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.urology.2019.10.007","volume":"135","author":"AF Saltzman","year":"2020","unstructured":"Saltzman AF, Carrasco A Jr, Amini A et al (2020) Patterns of care and survival comparison of adult and pediatric Wilms tumor in the United States: a study of the national cancer database. Urology 135:50\u201356","journal-title":"Urology"},{"key":"2251_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/15287399409531908","volume":"43","author":"BJ Pan","year":"1994","unstructured":"Pan BJ, Hong YJ, Chang GC et al (1994) Excess cancer mortality among children and adolescents in residential districts polluted by petrochemical manufacturing plants in Taiwan. J Toxicol Environ Health 43:117\u2013129","journal-title":"J Toxicol Environ Health"},{"key":"2251_CR49","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1097\/01.ju.0000140194.87974.56","volume":"172","author":"TM Soergel","year":"2004","unstructured":"Soergel TM, Cain MP, Misseri R et al (2004) Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol 172:1649\u20131651","journal-title":"J Urol"},{"key":"2251_CR50","doi-asserted-by":"publisher","first-page":"E727","DOI":"10.5489\/cuaj.3049","volume":"9","author":"B Gunlusoy","year":"2015","unstructured":"Gunlusoy B, Ceylan Y, Degirmenci T et al (2015) Urothelial bladder cancer in young adults: diagnosis, treatment and clinical behaviour. Can Urol Assoc J 9:E727-E730","journal-title":"Can Urol Assoc J"},{"key":"2251_CR51","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.5858\/arpa.2012-0322-OA","volume":"137","author":"ML Stanton","year":"2013","unstructured":"Stanton ML, Xiao L, Czerniak BA et al (2013) Urothelial tumors of the urinary bladder in young patients: a clinicopathologic study of 59 cases. Arch Pathol Lab Med 137:1337\u20131341","journal-title":"Arch Pathol Lab Med"},{"key":"2251_CR52","unstructured":"EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS). https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Non-Muscle-Invasive-Bladder-Cancer-2022.pdf. April 2022"},{"key":"2251_CR53","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/iju.14281","volume":"27","author":"H Matsumoto","year":"2020","unstructured":"Matsumoto H, Shiraishi K, Azuma H et al (2020) Clinical practice guidelines for bladder cancer 2019 uptate by the Japanese Urological Association: summary of the revision. Int J Urol 27:702\u2013709","journal-title":"Int J Urol"},{"key":"2251_CR54","unstructured":"EAU guidelines on muscle-invasive and metastatic bladder cancer. https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Muscle-Invasive-And-Metastatic-Bladder-Cancer-2022.pdf. April 2022"},{"key":"2251_CR55","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/S0140-6736(18)30996-6","volume":"391","author":"DJ Parekh","year":"2018","unstructured":"Parekh DJ, Reis IM, Castle EP et al (2018) Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet 391:2525\u20132536","journal-title":"Lancet"},{"key":"2251_CR56","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","volume":"21","author":"M Yin","year":"2016","unstructured":"Yin M, Joshi M, Meijer RP et al (2016) Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis. Oncologist 21:708\u2013715","journal-title":"Oncologist"},{"key":"2251_CR57","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1200\/JCO.2015.64.1076","volume":"34","author":"MD Galsky","year":"2016","unstructured":"Galsky MD, Stensland KD, Moshier E et al (2016) Effectiveness of adjuvant chemotherapy for locally advanced bladder cancer. J Clin Oncol 34:825\u2013832","journal-title":"J Clin Oncol"},{"key":"2251_CR58","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.kjms.2014.02.017","volume":"30","author":"O Telli","year":"2014","unstructured":"Telli O, Sarici H, Ozgur BC et al (2014) Urothelial cancer of bladder in young versus older adults: clinical and pathological characteristics and outcomes. Kaohsiung J Med Sci 30:466\u2013470","journal-title":"Kaohsiung J Med Sci"},{"key":"2251_CR59","first-page":"1975","volume-title":"SEER cancer statistics review","author":"N Howlader","year":"2010","unstructured":"Soft Tissue Sarcoma Committee of the Children's Oncology Group, Joshi D, Anderson JR, Paidas C et al (2004) Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer 42:64\u201373"},{"key":"2251_CR60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ctrv.2017.12.001","volume":"63","author":"X Xiao","year":"2018","unstructured":"Xiao X, Garbutt CC, Hornicek F et al (2018) Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications. Cancer Treat Rev 63:61\u201370","journal-title":"Cancer Treat Rev"},{"key":"2251_CR61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/ped.12867","volume":"58","author":"H Hosoi","year":"2016","unstructured":"Hosoi H (2016) Current status of treatment for pediatric rhabdomyosarcoma in the USA and Japan. Pediatr Int 58:81\u201387","journal-title":"Pediatr Int"},{"key":"2251_CR62","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1053\/spsu.2001.24695","volume":"10","author":"ES Wiener","year":"2001","unstructured":"Wiener ES, Anderson JR, Ojimba JI et al (2001) Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Semin Pediatr Surg 10:146\u2013152","journal-title":"Semin Pediatr Surg"},{"key":"2251_CR63","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S1470-2045(16)00162-5","volume":"17","author":"A Trama","year":"2016","unstructured":"EUROCARE-5 Working Group, Trama A, Botta L, Foschi R et al (2016) Survival of European adolescents and young adults diagnosed with cancer in 2000\u201307: population-based data from EUROCARE-5. Lancet Oncol 17:896\u2013906","journal-title":"Lancet Oncol"},{"key":"2251_CR64","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/cncr.11550","volume":"98","author":"A Ferrari","year":"2003","unstructured":"Ferrari A, Dileo P, Casanova M et al (2003) Rhabdomyosarcoma in adults: a retrospective analysis of 171 patients treated at a single institution. Cancer 98:571\u2013580","journal-title":"Cancer"},{"key":"2251_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2017.03.003","volume":"78","author":"A Ferrari","year":"2017","unstructured":"Ferrari A, Chi YY, De Salvo GL et al (2017) Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: a joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children\u2019s Oncology Group. Eur J Cancer 78:1\u20136","journal-title":"Eur J Cancer"},{"key":"2251_CR66","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1200\/JCO.21.01628","volume":"39","author":"R Venkatramani","year":"2021","unstructured":"Venkatramani R, Xue W, Randall RL et al (2021) Synovial sarcoma in children, adolescents, and young adults: a report from the Children\u2019s Oncology Group ARST0332 study. J Clin Oncol 39:3927\u20133937","journal-title":"J Clin Oncol"},{"key":"2251_CR67","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s10147-020-01753-3","volume":"25","author":"R Kamitani","year":"2020","unstructured":"Kamitani R, Matsumoto K, Takeda T et al (2020) Optimal treatment strategy for paratesticular liposarcoma: retrospective analysis of 265 reported cases. Int J Clin Oncol 25:2099\u20132106","journal-title":"Int J Clin Oncol"},{"key":"2251_CR68","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.urology.2012.10.016","volume":"81","author":"RG Rowe","year":"2013","unstructured":"Rowe RG, Thomas DG, Schuetze SM et al (2013) Ewing sarcoma of the kidney: case series and literature review of an often overlooked entity in the diagnosis of primary renal tumors. Urology 81:347\u2013353","journal-title":"Urology"},{"key":"2251_CR69","doi-asserted-by":"publisher","first-page":"66","DOI":"10.6004\/jnccn.2018.0001","volume":"16","author":"PF Coccia","year":"2018","unstructured":"Coccia PF, Pappo AS, Beaupin L et al (2018) Adolescent and young adult oncology, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 16:66\u201397","journal-title":"J Natl Compr Canc Netw"},{"key":"2251_CR70","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.3390\/cancers13194847","volume":"13","author":"SHM Janssen","year":"2021","unstructured":"Janssen SHM, van der Graaf WTA, van der Meer DJ et al (2021) Adolescent and young adult (AYA) cancer survivorship practices: an overview. Cancers 13:4847","journal-title":"Cancers"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02251-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-022-02251-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02251-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T15:57:45Z","timestamp":1673366265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-022-02251-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["2251"],"URL":"https:\/\/doi.org\/10.1007\/s10147-022-02251-4","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2022,12,17]]},"assertion":[{"value":"25 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}